Literature DB >> 33852847

Complement C5a promotes antigen cross-presentation by Peyer's patch monocyte-derived dendritic cells and drives a protective CD8+ T cell response.

Sae-Hae Kim1, Byeol-Hee Cho2, Kwang Soon Kim3, Yong-Suk Jang4.   

Abstract

The complement fragment C5a is closely associated with adaptive immune induction in the mucosa. However, the mechanisms that control CD8+ T cell responses by C5a have not been extensively explored. This study reveals that C5/C5a in the Peyer's patch (PP) subepithelial dome increases upon oral Listeria infection. We hypothesize that C5aR+ PP cells play an important role in the induction of antigen-specific T cell immunity. Using single-cell RNA sequencing, we identify C5aR- and lysozyme-expressing dendritic cells (C5aR+ LysoDCs) in PP and examine their role in CD8+ T cell immune induction. Stimulation of C5aR+ LysoDCs by C5a increases reactive oxygen species levels, leading to efficient antigen cross-presentation, which elicits an antigen-specific CD8+ T cell response. In C5-deficient mice, oral co-administration of C5a and Listeria enhances Listeria-specific cytotoxic T cell levels. Collectively, these findings suggest a role of the complement system in intestinal T cell immunity.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C5a receptor; CD8(+) T cell; Peyer’s patch; complement C5a; cross-presentation; dendritic cells

Mesh:

Substances:

Year:  2021        PMID: 33852847     DOI: 10.1016/j.celrep.2021.108995

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  4 in total

Review 1.  Dendritic cell functions in the inductive and effector sites of intestinal immunity.

Authors:  Cécilia Luciani; Fabian Tobias Hager; Vuk Cerovic; Hugues Lelouard
Journal:  Mucosal Immunol       Date:  2021-08-31       Impact factor: 7.313

Review 2.  Current status and perspectives on vaccine development against dengue virus infection.

Authors:  Jisang Park; Ju Kim; Yong-Suk Jang
Journal:  J Microbiol       Date:  2022-02-14       Impact factor: 2.902

Review 3.  Vaccine adjuvants to engage the cross-presentation pathway.

Authors:  Woojong Lee; M Suresh
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

4.  Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn's Disease.

Authors:  Kibrom M Alula; Dakota N Jackson; Andrew D Smith; Daniel S Kim; Kevin Turner; Elizabeth Odstrcil; Benny A Kaipparettu; Themistocles Dassopoulos; K Venuprasad; Linda A Feagins; Arianne L Theiss
Journal:  Cells       Date:  2021-05-29       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.